Skip to main content

Fasteris to Provide Agilent's SureSelect in Europe

NEW YORK (GenomeWeb News) – Agilent Technologies said today that Swiss genomics services company Fasteris will provide Agilent's target enrichment services for next-generation sequencing.

Fasteris was named the first European Certified-Service Provider for Agilent's SureSelect Target Enrichment System, Agilent said.

Fasteris demonstrated proficiency using the SureSelect system with Illumina's Genome Analyzer. Agilent and Illumina have a non-exclusive co-marketing agreement that supports the Agilent system as optimized for the Genome Analyzer.

Agilent said that using the SureSelect can increase the speed and cost-effectiveness of next-generation sequencing workflows, and enable life science researchers to focus on genomic regions rather than sequencing entire genomes.

The system requires three micrograms or less of genomic DNA, which allows scientists to use very small sample amounts for next-generation sequencing, the company said.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.